Stati Uniti - Ingliż - NLM (National Library of Medicine)

natural story co.,ltd. - undaria pinnatifida (unii: icv1ok7m1s) (undaria pinnatifida - unii:icv1ok7m1s), hydrolyzed glycosaminoglycans (bovine; 50000 mw) (unii: 997385v0vv) (hydrolyzed glycosaminoglycans (bovine; 50000 mw) - unii:997385v0vv) - special skincare for dry and sensitive skin with abundant moisture and sea algae extract apply proper amount to the skin

Malta - Ingliż - Medicines Authority

c & m marketing limited 3 ferdinando inglott street, attard atd 3134, malta - potassium glycerophosphate, sodium glycerophosphate, calcium glycerophosphate - oral liquid - potassium glycerophosphate 45.6 mg/ml sodium glycerophosphate 22.8 mg/ml calcium glycerophosphate 45.6 mg/ml - vitamins

Malta - Ingliż - Medicines Authority

c & m marketing limited 3 ferdinando inglott street, attard atd 3134, malta - paracetamol, caffeine, codeine phosphate - film-coated tablet - paracetamol 500 mg caffeine 30 mg codeine phosphate 8 mg - analgesics

Kanada - Ingliż - Health Canada

glaxosmithkline inc - urea; hydrocortisone acetate - cream - 10%; 1% - urea 10%; hydrocortisone acetate 1% - anti-inflammatory agents

Kanada - Ingliż - Health Canada

glaxosmithkline inc - hydrocortisone acetate; urea - lotion - 1%; 10% - hydrocortisone acetate 1%; urea 10% - anti-inflammatory agents

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ciclosporin, quantity: 1 mg/ml - eye drops, emulsion - excipient ingredients: medium chain triglycerides; cetalkonium chloride; glycerol; tyloxapol; poloxamer; sodium hydroxide; water for injections - treatment of severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciprofloxacin hydrochloride 3.5 mg/g equivalent to anhydrous ciprofloxacin base 3 mg/g - eye ointment - 3 mg/g - active: ciprofloxacin hydrochloride 3.5 mg/g equivalent to anhydrous ciprofloxacin base 3 mg/g excipient: liquid paraffin white soft paraffin

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

santen oy - timolol base - eye drops, solution - 0.25 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

santen oy - timolol base - eye drops, solution - 0.5 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.